Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Reducing Nucleotide Exposure on Bone Health (ReNew)

NCT03549689 is registered in ClinicalTrials.gov with Philip Grant as lead sponsor.

NCT NCT03549689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03549689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Reducing Nucleotide Exposure on Bone Health (ReNew)
Lead sponsor
Philip Grant
Phase
Phase 2
Overall status
Withdrawn
Start date
August 1, 2019
Completion date
July 1, 2021
Enrollment
0 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection, hiv/aids, osteopenia